Vemlidy-tafnat (25 mg)

Gilead Science, INC

“Vemlidy” contains Drug / Molecule called “Tanofovir Alafenamide”. Vemlidy is a Nucleotide Reverse Transcriptase Inhibitor (NRTI) and a novel ester prodrug of the antiretroviral. Vemlidy mimics normal DNA building blocks but is lacking a 3′-OH molecule required for phosphodiester bond linkage. Vemlidy causes early chain termination and prevents proviral DNA 27 transcription.

Category:

Indication

Vemlidy is used in the treatment of HIV infection and Chronic hepatitis B .

Note

Precaution

  • Vemlidy is a prescription drug and should be used under proper medical guidance and advice.
  • Treatment with Vemlidy should be suspended in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity .

Related products